Literature DB >> 2544644

Differential expression of functional adrenocorticotropic hormone receptors by subpopulations of lymphocytes.

B L Clarke1, K L Bost.   

Abstract

In an effort to investigate the presence of adrenocorticotropic hormone (ACTH) receptors on rat lymphocytes, cells were separated by a panning procedure into T and B cell populations. By using the radiolabeled ACTH agonist, (125I-Tyr23) phenylalanine2-norleucine4-ACTH1-24, substantial numbers of ACTH binding sites were detected on T and B lymphocytes, but not on thymocytes. Scatchard analysis revealed two types of binding sites on each cell population, one with Kd1 = 0.088 +/- 0.025 nM and one with Kd2 = 4.2 +/- 0.6 nM; however, the absolute number of binding sites per cell was different. B lymphocytes expressed approximately three times the number of Kd1 binding sites per cell when compared with T lymphocytes. However, ACTH receptor expression by these cell populations was not static as suggested by the ability to induce receptor expression via mitogens. B or T cells and thymocytes stimulated with the mitogens LPS or Con A, respectively, substantially increased their number of Kd1 binding sites per cell (approximately three-fold). Even more dramatic increases in Kd1 receptor expression (approximately 100-fold) were observed when comparing "normal" and stimulated thymocytes. To demonstrate that these ACTH binding sites were in fact functional, cAMP levels were measured in lymphocytes 10 min after exposure to varying concentrations of ACTH. Dose-dependent increases in cAMP levels were observed, with significant stimulation occurring with as little as 0.1 nM ACTH added. Taken together, these studies demonstrate the presence of functional ACTH receptors on normal, rat T and B lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2544644

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  ACTH enhancement of T-lymphocyte cytotoxic responses.

Authors:  Eve W Johnson; Thomas K Hughes; Eric M Smith
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

2.  Glucocorticoid production and regulation in thymus: of mice and birds.

Authors:  Celso E Gomez-Sanchez
Journal:  Endocrinology       Date:  2009-09       Impact factor: 4.736

3.  Steroidogenic activity of a peptide specified by the reversed sequence of corticotropin mRNA.

Authors:  B L Clarke; J E Blalock
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

4.  Dual signal transduction through delta opioid receptors in a transfected human T-cell line.

Authors:  B M Sharp; N A Shahabi; W Heagy; K McAllen; M Bell; C Huntoon; D J McKean
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

Review 5.  Neuroimmune Interactions: From the Brain to the Immune System and Vice Versa.

Authors:  Robert Dantzer
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

6.  Block of T lymphocyte differentiation by activation of the cAMP-dependent signal transduction pathway.

Authors:  E Lalli; P Sassone-Corsi; R Ceredig
Journal:  EMBO J       Date:  1996-02-01       Impact factor: 11.598

Review 7.  POMC: The Physiological Power of Hormone Processing.

Authors:  Erika Harno; Thanuja Gali Ramamoorthy; Anthony P Coll; Anne White
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

8.  Substance P production by P388D1 macrophages: a possible autocrine function for this neuropeptide.

Authors:  D W Pascual; K L Bost
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

9.  Adrenocorticotropin receptors: functional expression from rat adrenal mRNA in Xenopus laevis oocytes.

Authors:  L M Mertz; K J Catt
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

10.  Immunosuppressive effects of corticotropin and melanotropin and their possible significance in human immunodeficiency virus infection.

Authors:  E M Smith; T K Hughes; F Hashemi; G B Stefano
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.